(Q38344733)

2 September 2017

title

5-aminoimidazole-4-carboxamide ribonucleoside and AMP-activated protein kinase inhibit signalling through NF-κB. (English)

1 reference

2 September 2017

0 references

Marina Katerelos

1

1 reference

2 September 2017

Stuart J Mudge

2

1 reference

2 September 2017

David Stapleton

3

1 reference

2 September 2017

Russell B Auwardt

4

1 reference

2 September 2017

Scott A Fraser

5

1 reference

2 September 2017

C-G Chen

6

1 reference

2 September 2017

Bruce E Kemp

7

1 reference

2 September 2017

David A Power

8

1 reference

2 September 2017

publication date

20 April 2010

1 reference

Immunology & Cell Biology

2 September 2017

published in

1 reference

2 September 2017

volume

88

1 reference

2 September 2017

issue

7

1 reference

2 September 2017

page(s)

754-760

1 reference

https://scigraph.springernature.com/pub.10.1038/icb.2010.44

2 September 2017

exact match

0 references

cites work

The AMP-activated protein kinase--fuel gauge of the mammalian cell?

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Dealing with energy demand: the AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Role of the AMP-activated protein kinase in regulating fatty acid metabolism during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Identification of SNF1/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Identification and characterization of a novel sucrose-non-fermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

5-Aminoimidazole-4-Carboxamide Ribonucleoside. A Specific Method for Activating AMP-Activated Protein Kinase in Intact Cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

https://api.crossref.org/works/10.1038%2FICB.2010.44

1 reference

7 January 2021

Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent: importance of the endothelium.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

Pyrrolidine dithiocarbamate inhibits cytokine-induced VCAM-1 gene expression in rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

Identification and characterization of a novel sucrose-non-fermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

Effects of adenine nucleotide analogues on myocardial dysfunction during reperfusion after ischemia in dogs

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

Acadesine extends the window of protection afforded by ischaemic preconditioning

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

Characteristics of cell cultures derived from renal glomeruli

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

Inhibition of NF-kappaB activation by a dominant-negative mutant of IkappaBalpha

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

Adenosine nucleotides induce e-selectin expression in porcine endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

Isoform-specific purification and substrate specificity of the 5'-AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.44

7 January 2021

Identifiers

DOI

10.1038/ICB.2010.44

1 reference

Dimensions Publication ID

2 September 2017

1001774247

0 references

1 reference